News filed under ODD/BTA/FTA Status, newest first.
Showing 1–5 of 10 stories
Latest story
New smartSET™ capability expands continuous pulse oximetry monitoring with AI-driven detection...
Read story
FDA Designation Supports Development of Potential Treatment for Chronic Lumbosacral Radiculopathy...
Read story
A Major Step Forward for SMA Treatment Biogen has announced that the U.S. Food and Drug Administr...
Read story
Fast Track status + Phase 2/3 dosing marks a critical inflection point. A small biotech just made a...
Read story
The semaglutide price war in India just hit a new low. Eris Lifesciences Limited has launched its ge...
Read storyPage 1 of 2